Liwasag, Johny T.
HRN: 23-65-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/05/2023
CEFTRIAXONE 1G (VIAL)
09/05/2023
09/12/2023
IV
2 Grams
OD
T/C PTB Relapse; CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes